Corporis Medical
Primary tabs
About your organization / profile
Corporis Medical is a young medical device company, that specializes in the development and commercialization of innovative medical devices. Corporis Medical's current focus lies in the improvement of surgery outcomes by developing innovative medical solutions. These solutions will not only improve the safety and efficacy of surgeries but will also ease surgical procedures for surgeons and as a result, potentially save thousands of lives and reduce surgery accompanied healthcare costs. Our focus lies in Laparoscopic surgery
we have 2 products that are in clinical validation and entering regulatory approvals for Europe and USA. Mediclose is a single use suturing device for closure of trocar induced incisions. Clinical use cases proof that our device can shorten the time needed for closure by a factor 5.
Laprixa is a wound healing indicator providing surgeons an indications of tissue viability during surgery . The Laprixa disposable probe can be inserted through a trocar interoperative and measure tissue bloodpressure and provide an index for tissue healing capacity prior to resecting tissue. Proof of principle was verified in a clinical trial and the product is undergoing clinical validation and regulatory approvals.
Corporis Medical is financed by several venture capital funds and an institutional investor.
We are preparing for commercialization of our products and are raising capital to finance market roll out in Europe and US.
Network (0)
There are no organizations in the network.
Recent activities
Corporis Medical is now a member of the EIC ACCESS+ community.
The dataroom has been updated.
Corporis Medical is now a member of the EEN2EIC - Seal of Excellence community.
john Marugg has joined Corporis Medical.